News 17 Oct 2023 Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund Vaud-based start-ups Voltiris, Limula, and Parithera gain momentum in their innovative ventures as they secure vital funding and support from Bio...
Actualités 17 Oct 2023 Voltiris, Limula et Parithera bénéficient du Start-Up Fund du Biopôle Les start-up vaudoises Voltiris, Limula et Parithera accélèrent le développement de leurs projets innovants grâce à un soutien et un financement ...
News 14 Mar 2023 CSEM leads the industrialization of HiFiBiO’s complex microfluidic chips HiFiBiO Therapeutics and CSEM are collaborating to create and produce single-cell microfluidics, which have the potential to revolutionize immuno...
News 26 Mayo 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Actualités 08 Nov 2022 "Difficile de battre la qualité suisse; même les chinois le reconnaissent." UCB Établie en Belgique, UCB est une société biopharmaceutique active à l’international. Depuis 1996, elle a investi plus de 600 millions d...
News 06 Jul 2022 Clexbio and CSEM join forces to develop the first device to produce vein implants Norwegian start-up Clexbio and CSEM in Neuchâtel have joined forces to develop the world’s first device capable of cultivating human vein tissue ...
News 11 Mayo 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
Actualités 06 Jul 2022 Clexbio et le CSEM s’allient pour développer la première machine à produire des implants veineux La start-up norvégienne Clexbio et le CSEM à Neuchâtel s’allient pour développer la première machine au monde capable de cultiver en laboratoire ...
Actualités 11 Mayo 2022 CEIDOS et Limula reçoivent EUR 1.14 million d’Eurostars pour un dispositif innovant En collaboration avec Limula, la société valaisanne CEIDOS a reçu une bourse de EUR 1,14 million d'Eurostars pour développer un dispositif dédié ...
Success stories 09 Jun 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
News 09 Jun 2021 Swiss Motion Technologies’ 3D printed silicone sleeves get FIT boost Thanks to its automated manufacturing solution for improving disabled people’s mobility, Vaud-based start-up Swiss Motion Technologies was awarde...
News 02 Jun 2021 Eye diseases detection specialist EarlySight secures CHF 2.3 million EPFL spin-off EarlySight has secured CHF 2.3 million for the development of a medical device that helps doctors detect and treat eye diseases at ...
Success stories 25 Mayo 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...